Now, a study led by the University of Barcelona reveals that the functional assay dynamic BH3 profiling (DBP) can predict whether this treatment will be effective in these cancer patients and thus ...

The BH3 domain is an essential feature of all BCL2 ... these helices lose their secondary structure, and in vivo function is compromised. Most approaches to stabilize peptides leave them ...